SHRXF

Sharp Therapeutics Corp. has postponed its annual shareholder meeting to July 21, 2026, from the original June 30 date, and filed an amended and restated management information circular to include a resolution re-approving the company's stock option plan. The plan resolution was omitted from the original May 27 circular and proxy materials, so shareholders must disregard any previously submitted voting instructions and cast new votes using the updated proxy or voting instruction form. Proxies must be received by 10:00 a.m. Toronto time on July 17, 2026. The amended documents will be available on SEDAR+.